SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs earnings beat was overshadowed by softer revenue guidance, a reduced advertising outlook, and concerns about slowing growth, prompting analyst downgrades and price-target cuts. Traders are split between viewing the outlook and competition concerns as signs of a deeper growth problem and treating the selloff as an overreaction and buying opportunity.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro sharply raised its preliminary fiscal Q1 outlook on stronger AI-platform demand and improved gross-margin expectations, driving a rally. Traders largely welcomed the demand signal and speculated about a short squeeze, while skeptics questioned whether margins, cash flow and execution can sustain the move.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs strong third-quarter results, including its first profit as a public company and rapid AI-compute growth, prompted a rally and a wave of analyst upgrades. Traders are broadly upbeat, while skeptics point to heavy capital spending and upcoming share unlocks; a possible Tesla merger is also being discussed but remains exploratory.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&Ts earnings beat and higher outlook failed to prevent a selloff, with traders pointing to postpaid phone additions falling short of expectations. The reaction is debated as either concern about subscriber momentum and lingering SpaceX competition or an overreaction to otherwise solid results, with some investors buying the dip.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strives preferred-stock offering and continued Bitcoin purchases are driving discussion, with bulls viewing the financing as fuel for treasury growth while skeptics warn that dilution and preferred-dividend obligations could weigh on common shareholders.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabets upcoming earnings have traders focused on Google Cloud growth and whether AI investments can generate returns, amid widespread concern about heavy capital spending and speculation it could rise further. The debate is split between dip-buyers citing Alphabets AI and cloud businesses and bearish traders worried about spending, search disruption, and the shares persistent weakness.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is drawing attention after a steep memory-stock selloff amid fears that Chinese rival CXMT could intensify competition and pressure memory prices, alongside broader weakness in chip stocks. Traders are split between viewing the shares as oversold ahead of earnings and expecting further declines as sector and competitive risks persist.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is drawing attention for its sharp pullback and weak price action ahead of earnings, with traders watching whether cloud growth and AI investment can translate into returns. The discussion is split between dip-buyers citing its AI and quantum-computing progress and bearish traders focused on underperformance, technical support, and heavy capital spending.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is drawing attention amid persistent share-price weakness despite community references to ORLADEYO growth and profitable results, fueling criticism of management and calls for buybacks or a sale. Some traders point to future navenibart and Netherton data and continued ORLADEYO growth as potential catalysts, while skeptics focus on dilution, debt and uncertainty around the companys acquisition-led strategy.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Early Phase 1 azer-cel findings in progressive MS are the main focus, with traders highlighting reported deep B-cell depletion and disability or MRI signals as a potential growth story beyond BRIUMVI. The reaction is broadly optimistic but tempered by the small, preliminary study and uncertainty about whether the data will translate into meaningful clinical benefit; some also note the stocks muted, choppy response.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'

Equity

No plague case has been confirmed, and no government orders have been announced, but outbreak-linked stocks jumped anyway.

Investors Purchase High Volume of Call Options on Siga Technologies (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA - Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors acquired 1,200 call options on the stock. This is an increase of 1,438% compared to the typical daily volume of 78 call options...

Siga Technologies Target of Unusually High Options Trading (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA - Get Free Report) saw unusually large options trading activity on Wednesday. Stock investors acquired 1,200 call options on the company. This is an increase of...

Siga Technologies Sees Unusually High Options Volume (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA - Get Free Report) saw some unusual options trading activity on Wednesday. Traders bought 1,200 call options on the stock. This is an increase of 1,438% compared...

Why Are Siga Technologies Shares Trading Higher?

SIGA Technologies Inc. (NASDAQ: SIGA) shares are trading higher Friday after the company declared a special cash dividend of $0.60 per share.read more...

Siga Technologies Inc. Plans Dividend of $0.60 (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA) announced a dividend on Thursday, March 26th. Shareholders of record on Tuesday, April 7th will be paid a dividend of 0.60 per share on Thursday, April 23rd. The ex-dividend date of this dividend is Tuesday, April 7th...

Stock Traders Purchase Large Volume of Siga Technologies Call Options (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA - Get Free Report) was the target of unusually large options trading activity on Wednesday. Traders bought 1,200 call options on the stock. This represents an...

CSM Advisors LLC Has $5.46 Million Stake in Siga Technologies Inc. $SIGA

CSM Advisors LLC grew its stake in shares of Siga Technologies Inc. (NASDAQ:SIGA - Free Report) by 66.5% during the third quarter, according to the company in its most recent disclosure with the...

Siga Technologies Q4 Earnings Call Highlights

Siga Technologies (NASDAQ:SIGA) reported 2025 results and provided a business update focused on its role in global smallpox preparedness, highlighting product deliveries under its current U.S...

Traders Purchase High Volume of Call Options on Siga Technologies (NASDAQ:SIGA)

Siga Technologies Inc. (NASDAQ:SIGA - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors purchased 1,200 call options on the company. This is an...

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

SIGA Technologies Inc

Bullish Sentiment

<ul class="summary-bullets"><li><a class="mention" data-mention="$NVAX" data-symbol-id="NVAX" href="https://stocktwits.com/symbol/NVAX" target="_blank">NVAX</a> surged 20%, EBS gained 14%, ARCT rose 13% and MRNA climbed 7% amid the Russian plague scare.</li><li>The rally broadened to protective-equipment, antiviral and immune-profiling stocks, with LAKE gaining 15% and APT and NNVC each rising 13%.</li><li>Russian authorities called the regional situation stable, while the WHO assessed the public risk as low.</li></ul>A Russian lab worker’s unexplained death&nbsp;in a plague research institute sparked a rally across vaccine and biodefense stocks on Monday, with Novavax (NVAX), Moderna (MRNA), Emergent BioSolutions (EBS) and Arcturus Therapeutics (ARCT) advancing as retail investors speculated about federal contracts and further gains.NVAX surged 20%,&nbsp;<a href="https://stocktwits.com/symbol/EBS">EBS</a> climbed 14%,&nbsp;<a href="https://stocktwits.com/symbol/ARCT">ARCT</a> gained 13% and&nbsp;<a href="https://stocktwits.com/symbol/MRNA">MRNA</a> rose 7%. Buying spread to protective-equipment suppliers, testing companies and antiviral developers as traders revived familiar outbreak bets.<img src="https://news.stocktwits-cdn.com/outbreak_rally_9d23a20745.png" alt="outbreak rally.png">The rally also extended to protective-equipment makers&nbsp;<a href="https://stocktwits.com/symbol/APT">Alpha Pro Tech (APT)</a>, which rose 13% on Monday, and&nbsp;<a href="https://stocktwits.com/symbol/LAKE">Lakeland Industries (LAKE)</a>, which gained 15%. Antiviral developer&nbsp;<a href="https://stocktwits.com/symbol/NNVC">NanoViricides (NNVC)</a> climbed 13%, immune-profiling company&nbsp;<a href="https://stocktwits.com/symbol/VRAX">Virax Biolabs (VRAX)</a> advanced 10%, and smallpox-drug maker&nbsp;<a href="https://stocktwits.com/symbol/SIGA">Siga Technologies (SIGA)</a> added 3%.&nbsp;Cancer-immunotherapy developer&nbsp;<a href="https://stocktwits.com/symbol/IBRX">ImmunityBio (IBRX)</a>, which also featured in retail discussions about government demand, edged up 1%.&nbsp;&nbsp;<h2 class="st-heading-2">Trump’s Russia Offer Fuels Spending Hopes</h2>“We’ll help,” Trump said on Monday, calling the situation a “big problem for Russia,” Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/us/trump-says-us-will-help-russia-after-siberia-plague-institute-death-2026-10-05/">reported</a>. The remarks came after the death of Darya Shipilova, a 28-year-old lab technician at the Irkutsk Anti-Plague Research Institute in Siberia. She developed pneumonia of unknown origin, prompting quarantine measures and medical observation of people who had contact with her.Russia’s public health agency, Rospotrebnadzor, said samples contained no microorganisms associated with her professional duties and called the regional epidemiological situation stable.&nbsp;The WHO said that the risk to the general population appeared low based on available unofficial information. U.S. Secretary of State Marco Rubio also urged measured attention, calling the situation a “cause for focus,” according&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://edition.cnn.com/2026/10/05/world/video/rubio-says-situation-in-russia-is-cause-for-focus-but-not-alarm">to</a> CNN.The uncertainty nevertheless gave traders a familiar catalyst: the prospect that heightened preparedness could lead to government purchases.<h2 class="st-heading-2">Vaccine Makers Ride Outbreak Bets</h2>Novavax, Moderna and Arcturus have commercial vaccines, but their products do not target plague. Novavax developed Nuvaxovid, a protein-based COVID-19 vaccine containing its Matrix-M adjuvant. Matrix-M enhances immune responses and can be incorporated into other vaccines, giving the company broader vaccine-development and licensing exposure.Moderna markets COVID-19 vaccines, including Spikevax, and the RSV vaccine mRESVIA. Its mRNA tech makes it a familiar name in emerging-pathogen trades.&nbsp;Meanwhile, Arcturus has the commercial COVID-19 vaccine Kostaive and is developing ARCT-2304, an experimental H5N1 pandemic-influenza vaccine. BARDA fully funds the candidate’s Phase 1 study.<h2 class="st-heading-2">Stockpile Suppliers And PPE Makers Rally</h2>Emergent has a direct connection to government purchasing through its medical-countermeasure portfolio. BioThrax and Cyfendus are anthrax vaccines, while ACAM2000 is a smallpox and mpox vaccine. Tembexa, another portfolio product, is a smallpox antiviral. Its $24 million BARDA contract modification for Cyfendus, announced last month, shows its procurement model.&nbsp;Siga supplies TPOXX, a smallpox antiviral, to the Strategic National Stockpile. Lakeland and Alpha Pro Tech provide protective equipment. Lakeland supplies protective clothing, while Alpha Pro Tech manufactures disposable garments, masks and face shields.&nbsp;<h2 class="st-heading-2">Antiviral And Immunotherapy Names Join Rally</h2>Virax Biolabs focuses on immune-response detection and T-cell profiling, including applications in post-acute infection syndromes such as Long COVID. NanoViricides is developing NV-387, an antiviral drug candidate. Because plague is bacterial, its rally reflects broader outbreak sentiment rather than an established plague-treatment opportunity.Meanwhile, ImmunityBio markets Anktiva, a cancer immunotherapy, and develops immune-cell platforms.<h2 class="st-heading-2">How Do Retail Traders Feel About Outbreak Bets?</h2>On Stocktwits, retail sentiment for NVAX and EBS was ‘extremely bullish’ amid ‘extremely high’ message volume. ARCT drew ‘bullish’ sentiment with ‘normal’ chatter, while MRNA sentiment remained ‘neutral’ despite ‘high’ message volume.&nbsp;One user on EBS&nbsp;<a href="https://stocktwits.com/KnuckleSandwich/message/665783238">said</a>: “Contract awards are in bound....good timing with the Russia plague news fueling the momentum!!” The user added: “See you at 15++.. Might even hit 20 by year-end!” Another user on NVAX&nbsp;<a href="https://stocktwits.com/TobySmith1366/message/665803930">sees</a> a return to “operation warp speed” and “throwing billions at NVAX.”One user on APT&nbsp;<a href="https://stocktwits.com/Paretoprincipal/message/665752847">drew parallels</a> with a previous outbreak trade: “Hantavirus took APT from $4.50 to $7.50 this May. The plague should take us even higher.” Another user on NNVC&nbsp;<a href="https://stocktwits.com/insanitywolftrading/message/665786543">noted</a> that “every time there is a pandemic fear this makes a massive run.”So far this year, NVAX has gained 87%, MRNA has surged 589% and ARCT has climbed 139%, while EBS remains down 41%.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/spcx-stock-musk-trillionaire-sequoia-maguire-investors-starting-to-understand-spacex/cZDsnwARBjv">SPCX Stock Makes Musk A Trillionaire Again: Sequoia's Maguire Says Investors Are Just 'Starting To Understand SpaceX'&nbsp;</a>

Alpha Pro Tech Ltd.

Arcturus Therapeutics Holdings Inc

Emergent Biosolutions Inc

ImmunityBio Inc

Lakeland Industries, Inc.

Moderna Inc

NanoViricides Inc

Novavax Inc

Virax Biolabs Group Ltd

SPDR S&P Biotech ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.14
Prev Close	$3.15
Open	$3.15
Dividend Yield	0.00%
50-Day Moving Average	$3.15
Beta	0.85
Avg. Volume	692,664.29
PE Ratio	-79.55

52-Week High	$7.55
52-Week Low	$2.83
Market Capitalization	$226.33M
EPS (Annual)	$0.3239
Price to Book	1.37
Revenue Per Employee	$1.93M

Feed

News

Sentiment

Earnings

Fundamentals

Info

SIGA Fundamentals